Quantitative Volumetric Analysis Following Magnetic Resonance–Guided Laser Interstitial Thermal Ablation of Cerebellar Metastases

Daniel G. Eichberg, Ryan VanDenBerg, Ricardo J Komotar, Michael E. Ivan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Treating recurrent posterior fossa metastases after previous radiation therapy and surgical resection remains challenging. Magnetic resonance laser-induced thermal therapy (MR-LITT) is a promising treatment for recurrent lesions, but data on safety, efficacy, and postablation volume change in the posterior fossa are lacking. Methods: All patients with recurrent posterior fossa metastatic lesions treated with MR-LITT by the senior neurosurgeon were included in the study. Preoperative and postoperative follow-up magnetic resonance imaging (MRI) studies were used to measure lesional and perilesional edema volume. These measurements were compared to calculate percent ablation volume. All patients’ clinical examinations were followed closely. Results: Four patients with recurrent cerebellar metastases were treated with MR-LITT. The average percent lesion ablated was 97.1% (range, 88.2%–100%). The average preoperative lesion volume was 3.3 cm3 (range, 1.1–7.2 cm3), and the average final postoperative volume was 3.8 cm3 (range, 0.5–7.6 cm3). Lesion volume increased to maximum volume on postoperative day 1, with an average increase of 486.9%. The extrapolated average time for the lesion to shrink to below the initial size was 294.5 days. There was a trend toward a decrease in average edema volume from the preoperative MRI of 17.8 cm3 to final postoperative follow-up MRI of 3.4 cm3 (P = 0.0952). No postoperative hydrocephalus or complications occurred. Conclusions: This pilot study shows that LITT appears to be a safe and promising treatment for recurrent posterior fossa metastatic lesions up to 7.2 cm3. Further randomized controlled studies are warranted to further characterize the long-term efficacy of this therapy.

Original languageEnglish (US)
Pages (from-to)e755-e765
JournalWorld Neurosurgery
Volume110
DOIs
StatePublished - Feb 1 2018

Fingerprint

Lasers
Hot Temperature
Neoplasm Metastasis
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Edema
Therapeutics
Hydrocephalus
Radiotherapy
Safety

Keywords

  • Brain tumor
  • Magnetic resonance laser-induced thermal therapy
  • Metastasis
  • Minimally invasive surgery
  • Posterior fossa
  • Tumor recurrence

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Quantitative Volumetric Analysis Following Magnetic Resonance–Guided Laser Interstitial Thermal Ablation of Cerebellar Metastases. / Eichberg, Daniel G.; VanDenBerg, Ryan; Komotar, Ricardo J; Ivan, Michael E.

In: World Neurosurgery, Vol. 110, 01.02.2018, p. e755-e765.

Research output: Contribution to journalArticle

@article{b014e0bb6caa45109fd70e148946879a,
title = "Quantitative Volumetric Analysis Following Magnetic Resonance–Guided Laser Interstitial Thermal Ablation of Cerebellar Metastases",
abstract = "Background: Treating recurrent posterior fossa metastases after previous radiation therapy and surgical resection remains challenging. Magnetic resonance laser-induced thermal therapy (MR-LITT) is a promising treatment for recurrent lesions, but data on safety, efficacy, and postablation volume change in the posterior fossa are lacking. Methods: All patients with recurrent posterior fossa metastatic lesions treated with MR-LITT by the senior neurosurgeon were included in the study. Preoperative and postoperative follow-up magnetic resonance imaging (MRI) studies were used to measure lesional and perilesional edema volume. These measurements were compared to calculate percent ablation volume. All patients’ clinical examinations were followed closely. Results: Four patients with recurrent cerebellar metastases were treated with MR-LITT. The average percent lesion ablated was 97.1{\%} (range, 88.2{\%}–100{\%}). The average preoperative lesion volume was 3.3 cm3 (range, 1.1–7.2 cm3), and the average final postoperative volume was 3.8 cm3 (range, 0.5–7.6 cm3). Lesion volume increased to maximum volume on postoperative day 1, with an average increase of 486.9{\%}. The extrapolated average time for the lesion to shrink to below the initial size was 294.5 days. There was a trend toward a decrease in average edema volume from the preoperative MRI of 17.8 cm3 to final postoperative follow-up MRI of 3.4 cm3 (P = 0.0952). No postoperative hydrocephalus or complications occurred. Conclusions: This pilot study shows that LITT appears to be a safe and promising treatment for recurrent posterior fossa metastatic lesions up to 7.2 cm3. Further randomized controlled studies are warranted to further characterize the long-term efficacy of this therapy.",
keywords = "Brain tumor, Magnetic resonance laser-induced thermal therapy, Metastasis, Minimally invasive surgery, Posterior fossa, Tumor recurrence",
author = "Eichberg, {Daniel G.} and Ryan VanDenBerg and Komotar, {Ricardo J} and Ivan, {Michael E.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.wneu.2017.11.098",
language = "English (US)",
volume = "110",
pages = "e755--e765",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Quantitative Volumetric Analysis Following Magnetic Resonance–Guided Laser Interstitial Thermal Ablation of Cerebellar Metastases

AU - Eichberg, Daniel G.

AU - VanDenBerg, Ryan

AU - Komotar, Ricardo J

AU - Ivan, Michael E.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Background: Treating recurrent posterior fossa metastases after previous radiation therapy and surgical resection remains challenging. Magnetic resonance laser-induced thermal therapy (MR-LITT) is a promising treatment for recurrent lesions, but data on safety, efficacy, and postablation volume change in the posterior fossa are lacking. Methods: All patients with recurrent posterior fossa metastatic lesions treated with MR-LITT by the senior neurosurgeon were included in the study. Preoperative and postoperative follow-up magnetic resonance imaging (MRI) studies were used to measure lesional and perilesional edema volume. These measurements were compared to calculate percent ablation volume. All patients’ clinical examinations were followed closely. Results: Four patients with recurrent cerebellar metastases were treated with MR-LITT. The average percent lesion ablated was 97.1% (range, 88.2%–100%). The average preoperative lesion volume was 3.3 cm3 (range, 1.1–7.2 cm3), and the average final postoperative volume was 3.8 cm3 (range, 0.5–7.6 cm3). Lesion volume increased to maximum volume on postoperative day 1, with an average increase of 486.9%. The extrapolated average time for the lesion to shrink to below the initial size was 294.5 days. There was a trend toward a decrease in average edema volume from the preoperative MRI of 17.8 cm3 to final postoperative follow-up MRI of 3.4 cm3 (P = 0.0952). No postoperative hydrocephalus or complications occurred. Conclusions: This pilot study shows that LITT appears to be a safe and promising treatment for recurrent posterior fossa metastatic lesions up to 7.2 cm3. Further randomized controlled studies are warranted to further characterize the long-term efficacy of this therapy.

AB - Background: Treating recurrent posterior fossa metastases after previous radiation therapy and surgical resection remains challenging. Magnetic resonance laser-induced thermal therapy (MR-LITT) is a promising treatment for recurrent lesions, but data on safety, efficacy, and postablation volume change in the posterior fossa are lacking. Methods: All patients with recurrent posterior fossa metastatic lesions treated with MR-LITT by the senior neurosurgeon were included in the study. Preoperative and postoperative follow-up magnetic resonance imaging (MRI) studies were used to measure lesional and perilesional edema volume. These measurements were compared to calculate percent ablation volume. All patients’ clinical examinations were followed closely. Results: Four patients with recurrent cerebellar metastases were treated with MR-LITT. The average percent lesion ablated was 97.1% (range, 88.2%–100%). The average preoperative lesion volume was 3.3 cm3 (range, 1.1–7.2 cm3), and the average final postoperative volume was 3.8 cm3 (range, 0.5–7.6 cm3). Lesion volume increased to maximum volume on postoperative day 1, with an average increase of 486.9%. The extrapolated average time for the lesion to shrink to below the initial size was 294.5 days. There was a trend toward a decrease in average edema volume from the preoperative MRI of 17.8 cm3 to final postoperative follow-up MRI of 3.4 cm3 (P = 0.0952). No postoperative hydrocephalus or complications occurred. Conclusions: This pilot study shows that LITT appears to be a safe and promising treatment for recurrent posterior fossa metastatic lesions up to 7.2 cm3. Further randomized controlled studies are warranted to further characterize the long-term efficacy of this therapy.

KW - Brain tumor

KW - Magnetic resonance laser-induced thermal therapy

KW - Metastasis

KW - Minimally invasive surgery

KW - Posterior fossa

KW - Tumor recurrence

UR - http://www.scopus.com/inward/record.url?scp=85039458399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039458399&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2017.11.098

DO - 10.1016/j.wneu.2017.11.098

M3 - Article

C2 - 29180082

AN - SCOPUS:85039458399

VL - 110

SP - e755-e765

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

ER -